Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017034460) COMPOSITION AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INTESTINAL INFECTION AND INFLAMMATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/034460 International Application No.: PCT/SE2016/050787
Publication Date: 02.03.2017 International Filing Date: 23.08.2016
IPC:
A61K 35/747 (2015.01) ,C12N 1/20 (2006.01) ,A61P 1/00 (2006.01) ,C12R 1/225 (2006.01)
[IPC code unknown for A61K 35/747]
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1
Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
20
Bacteria; Culture media therefor
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1
Drugs for disorders of the alimentary tract or the digestive system
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
225
Lactobacillus
Applicants:
IMMUNEBIOTECH MEDICAL SWEDEN AB; Korsåkersvägen 53 226 50 Lund, --
Inventors:
AGHAIBEIK-LAVASANI, Shahram; SE
NOURI, Mehrnaz; SE
Agent:
AWAPATENT AB; Box 1066 251 10 Helsingborg, SE
Priority Data:
1551099-325.08.2015SE
Title (EN) COMPOSITION AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INTESTINAL INFECTION AND INFLAMMATION
(FR) COMPOSITION ET PROCÉDÉ POUR LE TRAITEMENT ET LA PROPHYLAXIE D'INFECTION ET D'INFLAMMATION INTESTINALE
Abstract:
(EN) The present invention relates to a composition for use in the treatment and/or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting of one L. salivarius strain, three L. plantarum strains and one L. brevis strain, wherein the L. salivarius strain is L. salivarius CW30 (LMG P- 28887), wherein the L. plantarum strains are L. plantarum Y1An734 (LMG P- 28886), L. plantarum SH1313 (LMG P-28884), and L. plantarum KS1 1 (LMG P-28885), and wherein the L. brevis strain is L. brevis SH1 1 1 (LMG P-28888). The present invention also relates to an enema comprising a composition according to the present invention. The present invention also relates to an isolated strain chosen from the group L. salivarius CW30 (LMG P-28887), L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P- 28884), L. plantarum KS11 (LMG P-28885) and L. brevis SH111 (LMG P- 28888). The present invention also relates to an isolated strain of L. salivarius CW30 (LMG P-28887) for use in the treatment and/or prevention of an infection by Clostridium difficile NAP/027.
(FR) La présente invention concerne une composition destinée à être utilisée dans le traitement et/ou la prévention d'un état gastro-intestinal, comprenant au moins une souche de Lactobacillus, la souche de Lactobacillus étant choisie parmi le groupe constitué d'une souche de L. salivarius, de trois souches de L. plantarum et d'une souche de L. brevis, la souche de L. salivarius étant L. salivarius CW30 (LMG P- 28887), les souches de L. plantarum étant L. plantarum Y1An734 (LMG P- 28886), L. plantarum SH1313 (LMG P-28884) et L. plantarum KS1 1 (LMG P-28885), et la souche de L. brevis étant L. brevis SH1 1 1 (LMG P-28888). La présente invention concerne également un lavement comprenant une composition selon la présente invention. La présente invention concerne également une souche isolée choisie parmi le groupe L. salivarius CW30 (LMG P-28887), L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P- 28884), L. plantarum KS11 (LMG P-28885) et L. brevis SH111 (LMG P- 28888). La présente invention concerne également une souche isolée de L. salivarius CW30 (LMG P-28887) destinée à être utilisée dans le traitement et/ou la prévention d'une infection par Clostridium difficile NAP/027.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)